Showing results (171-180 of 1,024) with videos related to

Sort By:
Pageof 103
Purinergic Signalling|March 28, 2008
Loss of apical monocilia on collecting duct principal cells impairs ATP secretion across the apical cell surface and ATP-dependent and flow-induced calcium signalsMichael B Hovater, Dragos Olteanu, Elizabeth L Hanson, et al.
Purinergic Signalling|March 28, 2008
Purinergic signalling in the subretinal space: a role in the communication between the retina and the RPEClaire H Mitchell, David Reigada
Purinergic Signalling|March 28, 2008
GTP avoidance in Tetrahymena thermophila requires tyrosine kinase activity, intracellular calcium, NOS, and guanylyl cyclaseJanine Bartholomew, Johnathan Reichart, Romie Mundy, et al.
Purinergic Signalling|March 28, 2008
P2 receptors in cardiovascular regulation and diseaseDavid Erlinge, Geoffrey Burnstock
Purinergic Signalling|March 28, 2008
Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypesChiara Bolcato, Claudia Cusan, Giorgia Pastorin, et al.
Purinergic Signalling|March 28, 2008
Remyelination after chronic spinal cord injury is associated with proliferation of endogenous adult progenitor cells after systemic administration of guanosineShucui Jiang, Patrizia Ballerini, Silvana Buccella, et al.
Purinergic Signalling|February 9, 2017
Hyperosmotic stress induces ATP release and changes in P2X7 receptor levels in human corneal and conjunctival epithelial cellsAna Guzman-Aranguez, María J Pérez de Lara, Jesús Pintor
Purinergic Signalling|November 11, 2016
Regulation of CD73 in the development of lower limb atherosclerosisJuho Jalkanen, Maija Hollmén, Sirpa Jalkanen, et al.
Purinergic Signalling|October 21, 2016
2',3'-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agentsDiego Dal Ben, Anna Marchenkova, Ajiroghene Thomas, et al.
Purinergic Signalling|July 22, 2019
Correction to: Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytesMolhm Nassir, Uri Arad, Sang-Yong Lee, et al.
Pageof 103